Cancer Indicators - Saratoga County
2007-2009
| Indicator | Data Links | 3 Year Total | County Rate | NYS Rate | Sig.Dif. | NYS Rate exc NYC | Sig.Dif. | County Ranking Group |
|---|---|---|---|---|---|---|---|---|
| All cancers | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 3,809 | 582.2 | 536.5 | Yes | 599.7 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 3,809 | 526.2 | 489.6 | Yes | 520.0 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 1,325 | 202.5 | 179.9 | Yes | 204.1 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 1,325 | 190.5 | 163.0 | Yes | 173.9 | Yes | 3rd |
| Lip, Oral Cavity, and Pharynx Cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 97 | 14.8 | 11.5 | Yes | 12.7 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 97 | 13.0 | 10.4 | No | 10.8 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 15 | 2.3 | 2.3 | No | 2.4 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 15 | 2.0 | 2.1 | No | 2.0 | No | 2nd |
| Colon and rectum cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 315 | 48.1 | 50.4 | No | 53.9 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 315 | 45.1 | 45.8 | No | 46.2 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 102 | 15.6 | 17.4 | No | 18.5 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 102 | 14.7 | 15.7 | No | 15.7 | No | 2nd |
| Lung and bronchus cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 565 | 86.4 | 69.8 | Yes | 83.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 565 | 79.4 | 63.8 | Yes | 72.2 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 393 | 60.1 | 46.9 | Yes | 57.2 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 393 | 56.9 | 42.8 | Yes | 49.0 | Yes | 3rd |
| Female breast cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 528 | 159.7 | 147.1 | No | 164.9 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 528 | 134.5 | 126.9 | No | 136.1 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 106 | 32.1 | 26.7 | No | 28.8 | No | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 106 | 26.6 | 21.7 | No | 22.2 | No | 4th |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 27 | 8.2 | 8.0 | No | 8.3 | No | 3rd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 27 | 6.6 | 6.8 | No | 6.8 | No | 3rd |
| Cervix uteri cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 26 | 7.9 | 8.9 | No | 7.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 26 | 7.3 | 8.3 | No | 7.4 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 2.1* | 2.7 | No | 2.2 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 2.0* | 2.3 | No | 1.9 | No | 3rd |
| Ovarian cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 56 | 16.9 | 15.2 | No | 16.5 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 56 | 14.2 | 12.9 | No | 13.4 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 44 | 13.3 | 9.6 | No | 11.0 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 44 | 11.1 | 7.8 | No | 8.5 | No | 4th |
| Prostate cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 556 | 171.8 | 169.1 | No | 186.0 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 556 | 156.7 | 166.9 | No | 171.2 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 47 | 14.5 | 18.5 | No | 19.2 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 47 | 17.7 | 21.6 | No | 20.8 | No | 1st |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 17 | 5.3 | 6.7 | No | 6.6 | No | 2nd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 17 | 5.7 | 7.2 | No | 6.6 | No | 2nd |
| Melanoma cancer mortality | ||||||||
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 23 | 3.5 | 2.3 | No | 3.1 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 23 | 3.4 | 2.1 | No | 2.7 | No | 4th |
| Age-adjusted % of women 18 years and older with pap smear in past 3 years (2008-2009) | (Table) (Map) | N/A | 82.3 | 82.7 | No | 82.6 | No | 2rd |
| % of women 40 years and older with mammography screening in past 2 years (2008-2009) | (Table) (Map) | N/A | 79.3 | 79.7 | No | 81.9 | No | 3nd |
N/A: Data not available
*: Fewer than 10 events in the numerator, therefore the rate is unstable
